New sniper tower, range to be built at Fort Indiantown Gap
FORT INDIANTOWN GAP, Pa. – A new snipe tower and training range are currently under construction at Fort Indiantown Gap.
The more than 500-acre combined-arms live-fire range is being built on an underutilized former tank gunnery range, while the sniper tower is being added to an existing sniper range. Both will be located between Blue and Second Mountains.
'This range and sniper tower will just add to the many diverse training options we have here at Fort Indiantown Gap,' said Col. Kevin Potts, garrison commander. 'And the fact that we were able to build them with a relatively small amount of money makes it even better.'
The live-fire range will be similar to one at Fort Bliss in Texas, which will allow for platoon live-fire.
'The western end of the training area was a blank slate, and it's just underutilized land,' said Lt. Col. Gordon Kinneer, Fort Indiantown Gap's director of plans, operations, training and security. 'We have a couple ranges there, but when those ranges aren't used, all that maneuver land just doesn't get used. So we saw it as an opportunity to get more usage out of it and build another capability.'
The three-story sniper tower is built from shipping containers welded together and shaped into rooms with different dimensions and configurations.
'It adds elevation, it adds realism,' Kinneer said. 'Yes, sniper teams can stalk through the woods, but they also operate out of urban terrain, and that's what we're seeking to replicate with that facility.'
The sniper tower is expected to be completed around September and the range by Spring 2026. It is usable now, but only at the squad and platoon level.
'We are continually assessing what we can do to enhance training opportunities for units that come to Fort Indiantown Gap to train,' Potts said. 'We do anything we can to ensure units are receiving top-notch training here.'
Download the abc27 News+ app on your Roku, Amazon Fire TV Stick, and Apple TV devices
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?
With a market cap of $14.3 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology firm, primarily focused on women's health. The company develops, manufactures, and sells a comprehensive suite of solutions, including molecular diagnostics, medical imaging systems, and surgical devices Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Hologic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. The company benefits from robust innovation, supported by over 7,000 patents, which fuels its proprietary technologies and product differentiation. Its diagnostics segment, particularly in molecular testing, has shown strong growth, positioning Hologic well in the expanding global healthcare market. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, HOLX shares have retreated 24.5% from their 52-week high of $84.67 touched on Aug. 9, 2024. Meanwhile, HOLX stock has surged 3.2% over the past three months, surpassing the SPDR S&P Health Care Equipment ETF's (XHE) 4.8% plunge over the same time frame. HOLX stock has plummeted 11.3% on a YTD basis and 10.5% over the past 52 weeks, compared to XHE's 10.6% dip in 2025 and a 6.3% fall over the past year. The stock has remained consistently below its 200-day moving average since early December last year, but has climbed above its 50-day moving average since late May. On May 27, HOLX shares surged more than 14%, leading S&P 500 gainers, after reports emerged that TPG Inc. (TPG) and Blackstone Inc. (BX) made (and were turned down on) a non-binding ~$16 billion takeover bid, valuing the company at $70–$72 per share. The stock's rally reflected investor optimism and underscored the premium valuation placed on its leadership in women's health and diagnostic capabilities. In the competitive healthcare equipment industry, top rival, Align Technology, Inc.'s (ALGN) 13.7% drop on a YTD basis and 25.7% decline over the past year trails HOLX's losses in the same time frames. Among the 19 analysts covering the HOLX stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $68.27 suggests a 6.7% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Lumen (LUMN) Subsidiary to Raise $1B for AI-Focused Debt Refinancing
Lumen Technologies, Inc. (NYSE:LUMN) is one of the 11 must-buy AI stocks analysts are betting on. On June 16, the company announced its wholly owned subsidiary Level 3 Financing plans to raise $1 billion in the market to refinance debt. An aerial view of a communications satellite in orbit, beaming its signal down to Earth. Level 3 will offer a $1 billion aggregate principal of First Lien Notes due in 2033. The unit will leverage net proceeds from the offering to redeem all $924.522 million in aggregate principal amount of senior secured notes due in 2030. The refinancing move extends the maturity date of Level 3 financing debt from 2030 to 2033. Lumen Technologies, Inc. (NYSE:LUMN) is a global communications and IT services company that offers solutions that help businesses connect people's data and applications securely. Its solutions also help companies realize artificial intelligence potential through its metro connectivity edge cloud and managed service capabilities. While we acknowledge the potential of LUMN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Healthcare Stocks to Buy Now and 10 Stocks Analysts Are Upgrading Today. Disclosure: None. Sign in to access your portfolio
Yahoo
a day ago
- Yahoo
Braze Inc (BRZE) Has Trembled 37% During the Year, Here's What You Need to Know Before Investing
Braze, Inc. (NASDAQ:BRZE) is one of the 11 Best Tech Stocks to Buy On the Dip. The company continues to face challenges from an uneven and noisy macroeconomic environment, noted the management. It has been facing elevated churn in the enterprise segment and prolonged deal cycles due to switching costs. Moreover, the weakness in the South Asian market has also resulted in falling investor sentiment. The stock has fallen more than 37% on a year-to-date basis due to these challenges. However, despite the market condition, Braze, Inc. (NASDAQ:BRZE) continued its momentum from FQ4 2025 and surpassed expectations with its FQ1 2026 results. It grew its revenue by 19.64% year-over-year to $162.06 million, surpassing estimates by $3.46 million. The EPS of $0.07 also exceeded expectations by $0.02. Notably, the company grew its GAAP-operating margins by more than 900 basis points and also marked the fourth consecutive quarter of profitability, with $7 million as net income. A web developer hunched over their laptop coding a customer engagement platform. The growth was driven by a growing customer base of 2,342 customers, which increased by 240 compared to the previous year, with a notable rise in large customers. In addition, Braze, Inc. (NASDAQ:BRZE) has been enhancing its AI capabilities, on March 27, it announced its agreement to acquire OfferFit, an AI decisioning company, for $325 million. The completion of this acquisition was announced in the FQ1 2026 earnings release. Management also highlighted notable business wins during the quarter including Beyond, Inc., Chamberlain Group, Evite, Freshket, Fubo, LUSH Cosmetics, Njuškalo, and ThredUp. Braze, Inc. (NASDAQ:BRZE) anticipates FQ2 2026 revenue to be between $171.0 million and $172.0 million, reflecting confidence in top-line growth. While we acknowledge the potential of BRZE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
